CDC Panel Considers Delaying Booster Jabs Decision By 1 Month To “Wait For More Evidence”
Last night, the FDA – as expected – authorized the emergency use of booster doses of the Pfizer-BioNTech mRNA jab for patients over the age of 65, the immuno-compromised, and the occupationally vulnerable.